Tuesday, May 05, 2009

Drug Maker supports Award for Mental Screening

The below press release is from Otsuka America Pharmaceutical which along with  Bristol-Myers Squibb are the makers of the antipsychotic drug Abilify.

American Psychiatric Foundation Names 2009 Recipients of Awards for Advancing Minority Mental Health

May. 5, 2009 08:01 AM

Awards Honoring Mental Health Programs Supported by a Grant from Otsuka America Pharmaceutical, Inc.

ROCKVILLE, Md., May 5 /PRNewswire/ -- Enhancing the quality of care and increasing awareness of and access to mental health care for underserved minority communities are all values held by the 2009 recipients of the American Psychiatric Foundation's (APF) Awards for Advancing Minority Mental Health.

The awards, presented by the APF and supported by a grant from Otsuka America Pharmaceutical, Inc. (OAPI), honor the commitment and efforts undertaken by psychiatrists and mental health providers who have organized timely and sustainable programs that help to provide for the mental health needs of minorities.

"We are proud to present these awards to these mental health professionals and organizations, which continue the strong commitment to reducing mental health disparities for racial and ethnic minorities," said Richard K. Harding, M.D., American Psychiatric Foundation president. "I congratulate all the recipients of the Awards for Advancing Minority Mental Health, and as a psychiatrist, commend all their efforts to educate and raise awareness of the mental health needs and services available. With education, we are well on our way to a national movement to eliminate the stigma associated with mental illness."

"We are proud to support the Awards for Advancing Minority Mental Health as part of our commitment to help eliminate health disparities among underserved populations," said Mark Altmeyer, president and chief executive officer of Otsuka America Pharmaceutical, Inc. "Otsuka congratulates the award recipients and applauds their efforts toward advancing minority mental health."

No comments: